Similar articles

• Combination chemotherapy--theory and practice.

  Capizzi RL, Keiser LW, Sartorelli AC. Capizzi RL, et al. Semin Oncol. 1977 Jun;4(2):227-53. Semin Oncol. 1977. PMID: 327555 Review. No abstract available.
• [Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].

  Kato T, Ishikawa K, Nemoto R. Kato T, et al. Nihon Hinyokika Gakkai Zasshi. 1977 Nov;68(11):1029-35. Nihon Hinyokika Gakkai Zasshi. 1977. PMID: 415167 Japanese. No abstract available.
• Drug sensitivity of rat bladder cancer in syngeneic hosts and athymic nude mice.

  Kitagawa H, Nakamura M, Kiuchi Y, Iwaguchi T. Kitagawa H, et al. Gan. 1981 Oct;72(5):802-5. Gan. 1981. PMID: 7327381
• Intravesical and systemic chemotherapy of murine bladder cancer.

  Soloway MS. Soloway MS. Cancer Res. 1977 Aug;37(8 Pt 2):2918-29. Cancer Res. 1977. PMID: 406041 Review. No abstract available.
• Chemotherapy of murine bladder cancer: in vitro and in vivo.

  Niell HB, Soloway MS, Matheny RB, Blatnik A. Niell HB, et al. Urology. 1984 Apr;23(4 Suppl):124-8. doi: 10.1016/s0090-4295(84)80082-5. Urology. 1984. PMID: 6710725 No abstract available.